Abstract
An 84-year-old right-hand dominant man, previously engineer, showed up in the clinic and asked for advice for treatment of his flexed fingers. He was being treated for hypertension, was on salicylic acid, and had twice been in surgery due to a colon cancer. Following the last surgery 4 years ago, the follow-ups had shown no signs of recurrence of his cancer. His current problem was his right hand. He was no longer able to shake hands with people, he had problems grasping an object, and the fingers “were in the way.” The flexed position of his fingers had gradually progressed during the last 2 years. He was familiar with the condition as he had seen several other family members with a somewhat similar appearance of their hands, and he had been surfing the Internet looking for different possibilities for treatment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Gudmundsson KG. Epidemiology of Dupuytren’s disease: clinical, serological, and social assessment The Reykjavik Study. J Clin Epidemiol. 2000;53(3):291–6.
Starkweather KD, Lattuga S, Hurst LC, Badalamente MA, Guilak F, Sampson SP, Dowd A, Wisch D. Collagenase in the treatment of Dupuytren’s disease: an in vitro study. J Hand Surg Am. 1996;21(3):490–5.
Badalamente MA, Hurst LC. Efficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytren’s contracture. J Hand Surg Am. 2007;32(6):767–74.
Hurst LC, Badalamente MA, Hentz VR, Hotchkiss RN, Kaplan FT, Meals RA, Smith TM, Rodzvilla J, CORD I Study Group. Injectable collagenase clostridium histolyticum for Dupuytren’s contracture. N Engl J Med. 2009;361(10):968–79.
Peimer CA, Wilbrand S, Gerber RA, Chapman D, Szczypa PP. Safety and tolerability of collagenase Clostridium histolyticum and fasciectomy for Dupuytren’s contracture. J Hand Surg. 2015;40(2):141–9.
Hentz VR. Collagenase injections for treatment of Dupuytren disease. Hand Clin. 2014;30(1):25–32.
Rodrigues JN, Zhang W, Scammell BD, Davis TR. What patients want from the treatment of Dupuytren’s disease-is the Unité Rhumatologique de Affections de la Main (URAM) scale relevant? J Hand Surg Eur. 2015;40(2):150–4.
Coleman S, Gilpin D, Kaplan FT, Houston A, Kaufman GJ, Cohen BM, Jones N, Tursi JP. Efficacy and safety of concurrent collagenase clostridium histolyticum injections for multiple Dupuytren contractures. J Hand Surgery Am. 2014;39(1):57–64.
Verheyden JR. Early outcomes of a sequential series of 144 patients with Dupuytren’s contracture treated by collagenase injection using an increased dose, multi-cord technique. J Hand Surg Eur. 2015;40(2):133–40.
Bainbridge C, Gerber RA, Szczypa PP, Smith T, Kushner H, Cohen B, Hellio Le Graverand-Gastineau MP. Efficacy of collagenase in patients who did and did not have previous hand surgery for Dupuytren’s contracture. J Plast Surg Hand Surg. 2012;46(3–4):177–83.
Hay DC, Louie DL, Earp BE, Kaplan FT, Akelman E, Blazar PE. Surgical findings in the treatment of Dupuytren’s disease after initial treatment with clostridial collagenase. J Hand Surg Eur. 2014;39(5):463–5.
Ball C, Pratt AL, Nanchahal J. Optimal functional outcome measures for assessing treatment for Dupuytren’s disease: a systematic review and recommendations for future practice. BMC Musculoskelet Disord. 2013;14:131.
Wilburn J, McKenna SP, Perry-Hinsley D, Bayat A. The Impact of Dupuytren disease on patient activity and quality of life. J Hand Surg. 2013;38(6):1209–14.
Badalamente M, Coffelt L, Elfar J, Gaston G, Hammert W, Huang J, Lattanza L, Macdermid J, Merrell G, Netscher D, Panthaki Z, Rafijah G, Trczinski D, Graham B. American Society for Surgery of the Hand Clinical Trials and Outcomes Committee. Measurement scales in clinical research of the upper extremity, part 2: outcome measures in studies of the hand/wrist and shoulder/elbow. J Hand Surg Am. 2013;38(2):407–12.
Suggested Readings
Atroshi I, Strandberg E, Lauritzson A, Ahlgren E, Waldén M. Costs for collagenase injections compared with fasciectomy in the treatment of Dupuytren’s contracture: a retrospective cohort study. BMJ Open. 2014;15(4):e004166. doi:10.1136/bmjopen-2013-004166.
McGrouther DA, Jenkins A, Brown S, Gerber RA, Szczypa P, Cohen B. The efficacy and safety of collagenase clostridium histolyticum in the treatment of patients with moderate Dupuytren's contracture. Curr Med Res Opin. 2014;30(4):733–9.
Mickelson DT, Noland SS, Watt AJ, Kollitz KM, Vedder NB, Huang JI. Prospective randomized controlled trial comparing 1. versus 7-day manipulation following collagenase injection for dupuytren contracture. J Hand Surgery Am. 2014;39(10):1933–41.
Peimer CA, Blazar P, Coleman S, Kaplan FT, Smith T, Tursi JP, Cohen B, Kaurman GJ, Lindau T. Dupuytren contracture recurrence following treatment with collagenase clostridium histolyticum (CORDLESS study): 3-year data. J Hand Surg Am. 2013;38(1):12–22.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Haugstvedt, JR. (2016). Clostridial Collagenase Injections in the Treatment of Dupuytren’s Contracture. In: Rizzo, M. (eds) Dupuytren’s Contracture. Springer, Cham. https://doi.org/10.1007/978-3-319-23841-8_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-23841-8_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-23840-1
Online ISBN: 978-3-319-23841-8
eBook Packages: MedicineMedicine (R0)